Skip to main content

Advertisement

SpringerLink
Log in

Steroid implant in anterior chamber of an aphakic vitrectomized eye

  • Letter to the Editor
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Jonas JB, Akkoyun I, Kreissig I, Degenring RF (2005) Diffuse diabetic macular edema treated by intravitreal triamcinolone acetonide. A comparative non-randomised study. Br J Ophthalmol 89:321–326

    Article  PubMed  CAS  Google Scholar 

  2. Jonas JB, Degenring RF, Kreissig I, Friedemann T, Akkoyun I (2005) Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative non-randomized study. Eye 19:163–170

    Article  PubMed  CAS  Google Scholar 

  3. Haller JA, Bandello F, Jr Belfort R, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM, OZURDEX GENEVA Study Group (2010) Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 117:1134.e3–1146.e3

    Article  Google Scholar 

  4. Chang-Lin JE, Attar M, Acheampong AA, Robinson MR, Whitcup SM, Kuppermann BD, Welty D (2011) Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. Invest Ophthalmol Vis Sci 52:80–86

    Article  PubMed  CAS  Google Scholar 

  5. Lowder C, Jr Belfort R, Lightman S, Foster CS, Robinson MR, Schiffman RM, Li XY, Cui H, Whitcup SM, Ozurdex HURON Study Group (2011) Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol 129:545–553

    Article  PubMed  Google Scholar 

  6. Boyer DS, Faber D, Gupta S, Patel SS, Tabandeh H, Li XY, Liu CC, Lou J, Whitcup SM, Ozurdex CHAMPLAIN Study Group (2011) Dexamethasone intravitreal implant for treatment of macular edema in vitrectomized patients. Retina 31:915–923

    Article  PubMed  CAS  Google Scholar 

  7. Summary of Product Characteristics. http://ec.europa.eu/health/documents/community-register/2010/2010072781690/anx_81690_en.pdf; Page 4, paragraph 6 (assessed September 6th, 2011)

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Medical Faculty Mannheim of the Ruprecht-Karls-University of Heidelberg, Mannheim, Germany

    Jost B. Jonas & Matthias Schmidbauer

  2. Universitäts-Augenklinik, Theodor-Kutzer-Ufer 1–3, 68167, Mannheim, Germany

    Jost B. Jonas

Authors
  1. Jost B. Jonas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matthias Schmidbauer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jost B. Jonas.

Additional information

Proprietary interest: Consultant for Allergan Inc.; Merck & Co., Inc.; Pfizer Inc.; Bayer-Schering Co.; CellMed AG, Alzenau, Germany; SOOFT SpA Montegiorgio, Italy; Patent holder with CellMed AG, Alzenau, Germany

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jonas, J.B., Schmidbauer, M. Steroid implant in anterior chamber of an aphakic vitrectomized eye. Graefes Arch Clin Exp Ophthalmol 251, 385–386 (2013). https://doi.org/10.1007/s00417-011-1839-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-011-1839-x

Keywords

Search

Navigation